Notice2024-11604
Office of The Director, National Institutes of Health; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 28, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 103 (Tuesday, May 28, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 103 (Tuesday, May 28, 2024)]
[Notices]
[Page 46148]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-11604]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of The Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Novel and
Exceptional Technology and Research Advisory Committee.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting should notify the Contact Person listed below in
advance of the meeting. The meeting will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (<a href="https://videocast.nih.gov/">https://videocast.nih.gov/</a>).
Name of Committee: Novel and Exceptional Technology and Research
Advisory Committee.
Date: June 17, 2024.
Time: 11:30 a.m. to 1:00 p.m.
Agenda: The Novel and Exceptional Technology and Research
Advisory Committee (NExTRAC) will receive an update from the Working
Group on Engaging the Public as Partners in Clinical Research and
discuss the next steps regarding the current charge to the
committee, delivered in August 2023.
Place: National Institutes of Health, 6705 Rockledge Drive,
Suite 630, Bethesda, MD 20892 (Virtual Meeting).
This meeting is a virtual meeting and can be accessed at:
<a href="https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4/">https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4/</a>).
Contact Person: Jessica Tucker, Ph.D., Acting Deputy Director,
Office of Science Policy, National Institutes of Health, 6705
Rockledge Drive, Suite 630, Bethesda, MD 20892, 301-496-9838,
<a href="/cdn-cgi/l/email-protection#4310202a262d2026132c2f2a203a032c276d2d2a2b6d242c35"><span class="__cf_email__" data-cfemail="10437379757e7375407f7c797369507f743e7e79783e777f66">[email protected]</span></a>.
Any interested person may file written comments by forwarding
the statement to the Contact Person listed on this notice at least
two business days prior to the meeting date. The statement should
include the name, address, telephone number and when applicable, the
business or professional affiliation of the interested person. Other
than name and contact information, please do not include any
personally identifiable information or any information that you do
not wish to make public. Proprietary, classified, confidential, or
sensitive information should not be included in your comments.
Please note that any comments NIH receives may be posted unredacted
to the Office of Science Policy website.
Information is also available on the NIH Office of Science
Policy website: <a href="https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4">https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4</a>,
where an agenda, link to the webcast meeting, and any additional
information for the meeting will be posted when available. Materials
for this meeting will be posted prior to the meeting. Please check
this website for updates.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: May 21, 2024.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-11604 Filed 5-24-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 28, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.